Non-invasive tumor microenvironment evaluation and treatment response prediction in gastric cancer using deep learning radiomics.

Journal: Cell reports. Medicine
Published Date:

Abstract

The tumor microenvironment (TME) plays a critical role in disease progression and is a key determinant of therapeutic response in cancer patients. Here, we propose a noninvasive approach to predict the TME status from radiological images by combining radiomics and deep learning analyses. Using multi-institution cohorts of 2,686 patients with gastric cancer, we show that the radiological model accurately predicted the TME status and is an independent prognostic factor beyond clinicopathologic variables. The model further predicts the benefit from adjuvant chemotherapy for patients with localized disease. In patients treated with checkpoint blockade immunotherapy, the model predicts clinical response and further improves predictive accuracy when combined with existing biomarkers. Our approach enables noninvasive assessment of the TME, which opens the door for longitudinal monitoring and tracking response to cancer therapy. Given the routine use of radiologic imaging in oncology, our approach can be extended to many other solid tumor types.

Authors

  • Yuming Jiang
    Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Kangneng Zhou
    School of Computer and Communication Engineering, University of Science and Technology Beijing, Beijing, 100083, China.
  • Zepang Sun
    Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Hongyu Wang
    School of Information Science and Technology, Northwest University, Xi'an, Shaanxi, China.
  • Jingjing Xie
    Beijing University of Posts and Telecommunications, China.
  • Taojun Zhang
    Department of General Surgery & Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, The First School of Clinical Medicine, Southern Medical University, Guangzhou, China.
  • Shengtian Sang
    School of Computer Science and Technology, Dalian University of Technology, Dalian, China. sangst@mail.dlut.edu.cn.
  • Md Tauhidul Islam
    Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
  • Jen-Yeu Wang
    Department of Radiation Oncology, Stanford University School of Medicine, 875 Blake Wilbur Drive, Stanford, CA, 94305, USA.
  • Chuanli Chen
    Department of Medical Imaging Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Qingyu Yuan
    Nanfang PET Center, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
  • Sujuan Xi
    Guangdong Key Laboratory of Liver Disease Research, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Tuanjie Li
    Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China. gzliguoxin@163.com caishirong@yeah.net ehbhltj@hotmail.com keekee77@126.com.
  • Yikai Xu
  • Wenjun Xiong
    Department of Gastrointestinal Surgery, Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Wei Wang
    State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau 999078, China.
  • Guoxin Li
    Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China. gzliguoxin@163.com caishirong@yeah.net ehbhltj@hotmail.com keekee77@126.com.
  • Ruijiang Li
    Global Station for Quantum Medical Science and Engineering, Global Institution for Collaborative Research and Education (GI-CoRE), Proton Beam Therapy Center, North 14 West 5 Kita-ku, Sapporo, Hokkaido, 060-8648, Japan.